Use App
Trending
News
Earnings
All
DIA
0.73%
SPY
0.54%
QQQ
0.86%
Trending
SPCX
23.54%
ROKU
20.44%
RIG
0.17%
AMP
0.11%
PLTR
2.20%
SPRY
3.34%
TROLL
5.29%
AMRN
4.03%
PSKY
2.57%
TQQQ
2.66%
SPCX
23.54%
ROKU
20.44%
RIG
0.17%
AMP
0.11%
PLTR
2.20%
SPRY
3.34%
TROLL
5.29%
AMRN
4.03%
PSKY
2.57%
TQQQ
2.66%
home
Symbol
GRI
news
GRI
GRI Bio Inc
$2.30
$0.06
(2.60%)
Today
·
Closed $2.25
$0.0481
(2.14%)
After Hours
Updated:
07:28 PM EDT
6
,
6
7
0
6
,
6
7
0
Mkt Cap
$4.09M
Vol
51,046.00
Full Chart
Fundamentals
Mkt Cap
$4.09M
Volume
-
52W High
$80.36
52W Low
$1.97
PE Ratio
-0.03
Avg. Volume
32,700.12
EPS (Annual)
-$121.80
P/B
0.35
Rev/Employee
$0.00
Earnings
-
Feed
News
Sentiment
Fundamentals
Info
News
all
press releases
GRI Bio Reports Positive Study Results For Chronic Lung Disease, But Stock Slumps 20% — What Happened?
The company said that the new data indicate that GRI-0621 may support the regeneration of lung tissue.
Stocktwits
Full Article
GRI Bio Drug Shows Promising Lung Function Recovery In Patients With Thickened Lungs
GRI Bio shared promising data from a Phase 2a trial for idiopathic pulmonary fibrosis, a chronic lung disease with no known cause.read more...
Benzinga
Barclays lifts Kojamo, I-RES ratings; cuts Grainger on low yield
investing.com
<
...
1
>
Advertisement
|
Remove ads.
Latest GRI News
View
GRI Bio Reports Positive Study Results For Chronic Lung Disease, But Stock Slumps 20% — What Happened?
Stocktwits
GRI Bio Drug Shows Promising Lung Function Recovery In Patients With Thickened Lungs
Benzinga
Barclays lifts Kojamo, I-RES ratings; cuts Grainger on low yield
investing.com
Loading...
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile